Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population

M. B. Edmonson, D. G. Addiss, J. T. McPherson, J. L. Berg, S. R. Circo and J. P. Davis
Department of Pediatrics, University of Wisconsin, Madison 53792.

A prolonged school-based outbreak of measles provided an opportunity to study "vaccine-modified" mild measles and secondary vaccine failure. Thirty-six (97%) of 37 unvaccinated patients had rash illnesses that met the Centers for Disease Control clinical case definition of measles, but 29 (15%) of 198 vaccinated patients did not, primarily because of low-grade or absent fever. Of 122 patients with seroconfirmed measles, 10 patients (all previously vaccinated) had no detectable measles-specific IgM and significantly milder illness than either vaccinated or unvaccinated patients with IgM-positive serum. Of 108 vaccinated patients with seroconfirmed measles, 17 patients (16%) had IgM-negative serology or rash illnesses that failed to meet the clinical case definition; their mean age (13 years), age at the time of vaccination, and time since vaccination did not differ from those of other vaccinated patients. The occurrence of secondary vaccine failure and vaccine-modified measles does not appear to be a major impediment to measles control in the United States but may lead to underreporting of measles cases and result in overestimation of vaccine efficacy in highly vaccinated populations.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Measles in the United States, 2006.
Mulholland
NEJM 2006;355:440-443.
FULL TEXT  

Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
Santibanez et al.
J. Gen. Virol. 2005;86:365-374.
ABSTRACT | FULL TEXT  

Identification of Primary and Secondary Measles Vaccine Failures by Measurement of Immunoglobulin G Avidity in Measles Cases during the 1997 Sao Paulo Epidemic
Pannuti et al.
CVI 2004;11:119-122.
ABSTRACT | FULL TEXT  

Evaluation of Hemagglutinin Protein-Specific Immunoglobulin M for Diagnosis of Measles by an Enzyme-Linked Immunosorbent Assay Based on Recombinant Protein Produced in a High-Efficiency Mammalian Expression System
Bouche et al.
J. Clin. Microbiol. 1998;36:3509-3513.
ABSTRACT | FULL TEXT  

Age for Routine Administration of the Second Dose of Measles-Mumps-Rubella Vaccine
Committee on Infectious Diseases
Pediatrics 1998;101:129-133.
ABSTRACT | FULL TEXT  

The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program
Peltola et al.
NEJM 1994;331:1397-1402.
ABSTRACT | FULL TEXT  

The 1993 Epidemic of Pertussis in Cincinnati -- Resurgence of Disease in a Highly Immunized Population of Children
Christie et al.
NEJM 1994;331:16-21.
ABSTRACT | FULL TEXT